CLAIM #3153 · Abbott Laboratories (ABT) · 2024Q2 earnings call · Jul 18, 2024 · due Dec 31, 2024
“With several recent large account wins expected to increasingly contribute to growth in the second half of the year.”
Robert Ford · CEO
PENDING
graded after results covering Dec 31, 2024 are reported
Verify independently
SEC filings for ABT ↗ · Claim quote is verbatim from the 2024Q2 earnings call.